⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12134091 | 1.00 | — | — | |
| SCHEMBL11568598 | 1.00 | — | — | |
| SCHEMBL407879 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL6295547 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL17275407 | 0.96 | — | — | |
| Butane SCHEMBL10936374 | 0.87 | SLC15A1 (0.40) | — | |
| SCHEMBL9346281 | 0.87 | SLC7A5 (0.35) | — | |
| SCHEMBL3239625 | 0.78 | — | — | |
| Alanine SCHEMBL6160093 | 0.77 | SLC7A5 (0.53) | — | |
| Alanine SCHEMBL468682 | 0.77 | SLC7A5 (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295790-A1 | LECTIN-TARGETING CONJUGATES | HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) | 2025-09-25 | — | — | US | disclosed |
| WO-2025126050-A1 | CHIMERIC ADJUVANT | DANGERFIELD EMMA (NZ) | 2025-06-19 | — | — | WO | disclosed |
| EP-4444355-A2 | LECTIN-TARGETING CONJUGATES | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2024-10-16 | — | — | EP | disclosed |
| US-20240067702-A1 | LACTAM-MODIFIED POLYPEPTIDE COMPOUNDS | TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. (CN) | 2024-02-29 | — | — | US | disclosed |
| US-11817553-B2 | Deep eutectic solvent-based gel polymer electrolytes | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-11-14 | — | — | US | disclosed |
| US-11787825-B2 | Therapeutic compounds for HIV virus infection | GILEAD SCIENCES, INC. (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230310634-A1 | ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF | IMMUNEXT INC (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230203069-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES, INC. | 2023-06-29 | — | — | US | disclosed |
| WO-2023104922-A2 | LECTIN-TARGETING CONJUGATES | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2023-06-15 | — | — | WO | disclosed |
| US-11497788-B2 | Supramolecular glycosaminoglycans | NORTHWESTERN UNIVERSITY (US) | 2022-11-15 | — | — | US | disclosed |
| US-20070276017-A1 | Thiadiazoline Derivative | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2007-11-29 | — | — | US | disclosed |
| US-20070270439-A1 | THROMBIN RECEPTOR ANTAGONISTS | SCHERING CORPORATION | 2007-11-22 | — | — | US | disclosed |
| US-20070238694-A1 | Purine compounds and methods of use thereof | INOTEK PHARMACEUTICALS CORPORATION (US) | 2007-10-11 | — | — | US | disclosed |
| US-20070179187-A1 | THROMBIN RECEPTOR ANTAGONISTS | SCHERING CORPORATION | 2007-08-02 | — | — | US | disclosed |
| US-20070149604-A1 | Reacting perindopril in a solvent selected from N,N-dimethylformamide, dimethoxymethane, 2,2-dimethoxypropane and 1,2-dimethoxyethane with tert-butylamine, crystallization; stereospecific | LUPIN LTD. (IN) | 2007-06-28 | — | — | US | disclosed |
| US-7176214-B2 | Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-02-13 | — | — | US | disclosed |
| US-7157594-B2 | 6-Fluorobicyclo[3.1.0]hexane derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |
| US-7157594-B2 | 6-Fluorobicyclo[3.1.0]hexane derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |
| US-4760180-A | N-terminally substituted dipeptide amides | G. D. SEARLE & CO. (US) | 1988-07-26 | — | — | US | disclosed |
| EP-0213481-A2 | N-terminally substituted dipeptide amides No. 2 | G.D. Searle & Co. (US) | 1987-03-11 | — | — | EP | disclosed |